Denali Therapeutics Inc.DNLINASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 336 | 49↓85.5% | 108↑122.9% | 331↑204.7% | 0 |
| Gross Profit | 336 | 49↓85.5% | 108↑122.9% | 331↑204.7% | 0 |
| Operating Income | 63 | -296↓571.6% | -341↓15.2% | -197↑42.3% | -487↓147.8% |
| Net Income | 71 | -291↓508.5% | -326↓12.2% | -145↑55.5% | -423↓191.1% |
| EBITDA | 71 | -287↓503.0% | -330↓15.0% | -180↑45.5% | -493↓173.9% |
| EPS Diluted | 0.63 | -2.39↓479.4% | -2.60↓8.8% | -1.06↑59.2% | -2.57↓142.5% |